Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
164.83
+4.00 (2.49%)
Dec 20, 2024, 4:00 PM EST - Market closed

Krystal Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Net Income
52.3710.93-139.98-69.57-32.17-19.09
Upgrade
Depreciation & Amortization
4.085.014.062.771.851.09
Upgrade
Loss (Gain) From Sale of Assets
0.03-99.970.07-0.030.07
Upgrade
Loss (Gain) From Sale of Investments
-5.58-5.09-0.57---
Upgrade
Stock-Based Compensation
45.6239.9333.2315.323.271.24
Upgrade
Other Operating Activities
1.01-1.73-0.191.040.01-
Upgrade
Change in Accounts Receivable
-87.98-42.04----
Upgrade
Change in Inventory
-5.88-4.48----
Upgrade
Change in Accounts Payable
1.38-0.1-1.250.710.78-0.2
Upgrade
Change in Other Net Operating Assets
58.38.734.071.790.13-1.8
Upgrade
Operating Cash Flow
63.35-88.8-100.57-47.94-26.08-18.69
Upgrade
Capital Expenditures
-5.28-11.8-52.98-68.34-14.84-6.4
Upgrade
Sale of Property, Plant & Equipment
-100----
Upgrade
Investment in Securities
-84.54-5.56-61.1-158.433.661.41
Upgrade
Investing Cash Flow
-89.8282.64-114.08-226.77-11.18-4.99
Upgrade
Issuance of Common Stock
32.59203.536355.65118.02107.53
Upgrade
Repurchase of Common Stock
-5.39-0.75-0.65---
Upgrade
Other Financing Activities
----7.96--
Upgrade
Financing Cash Flow
27.21202.7535.35347.69118.02107.53
Upgrade
Foreign Exchange Rate Adjustments
-0-0.16-0.04---
Upgrade
Net Cash Flow
0.73196.43-179.3572.9880.7683.84
Upgrade
Free Cash Flow
58.06-100.6-153.55-116.27-40.93-25.09
Upgrade
Free Cash Flow Margin
24.04%-198.43%----
Upgrade
Free Cash Flow Per Share
1.97-3.63-6.02-5.24-2.18-1.58
Upgrade
Levered Free Cash Flow
42.38-74.41-89.35-85.35-19.98-18.93
Upgrade
Unlevered Free Cash Flow
42.38-74.41-89.35-84.41-19.98-18.93
Upgrade
Change in Net Working Capital
42.6346.79-2.15-9.51-10.371.06
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.